Companies/US/STTK

SHATTUCK LABS, INC.

Last · NASDAQ$5.33-0.16 (-2.91%)close · yahoo · 19h ago
Vol 1.20M ≈ 6.41M
Market cap$534.94M100.4M sh
P/E · TTM-11.6fwd -10.3 · eps -0.46 · loss
Beta1.10vs S&P 500
Div yield0.00%annual · TTM
52w range
$1.72$8.33
Volume1.2Msession

Issuer

Legal nameSHATTUCK LABS, INC.
HQUnited States (US)
ListingUS STTK
ISINUS82024L1035
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001680367
CIK0001680367
LinkedIn
Employees40
AddressShattuck Labs, Inc. 500 West 5th Street 78701, Austin
Headline financial metrics
Revenue$5.7M
Operating income$-80.6M
Net income$-75.4M
Free cash flow$-60.6M
Operating margin-1408.3%
Net margin-1318.1%
Return on equity-94.7%
Period2024
Loading chart…

OpenFilings analyst

Our analyst

10-K · 2026-03-05

From latest 10-K · 2026-03-05

  • Sbc Revenue High
  • Operating Cf Burn
  • Net Margin Sharply Negative
  • Cash Conversion Weak
  • Cash Runway Low
  • Accumulated Deficit High
  • Rd Intensity High

Red flags

  • Sbc Revenue High — SBC/Revenue 699.5%
  • Operating Cf Burn — Negative operating cash flow
  • Net Margin Sharply Negative — Net margin -4880.9%
  • Cash Conversion Weak — Cash conversion (CFO/Rev) -3988.2%
  • Cash Runway Low — Cash runway ~1.4 years
  • Accumulated Deficit High — Accumulated deficit / equity 523%
  • Rd Intensity High — R&D/Revenue 3527.3%

Upcoming earnings

1 event
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.11
Est. revenue
37,500

Earnings transcripts

7 recent

Press & signals

1 recent
  • GlobeNewswire

    Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Documents

FormReporting forFiledFlags
2026-06-302026-08-11 3
—2026-08-110
2026-07-022026-07-070
2026-06-302026-07-020